microalbuminuria


Also found in: Dictionary, Acronyms, Wikipedia.
Related to microalbuminuria: macroalbuminuria

microalbuminuria

 [mi″kro-al-bu″min-u´re-ah]
an increase in urinary albumin excretion too subtle to be measured by conventional means, often seen with the hyperfiltration of diabetes mellitus.

mi·cro·al·bu·min·u·ri·a

(mī'krō-al-byū'min-yū'rē-ă),
A slight increase in urinary albumin excretion that can be detected using immunoassays but not using conventional urine protein measurements; an early marker for renal disease in patients with diabetes.
[micro- + albuminuria]

microalbuminuria

The excretion of 30–300 mg albumin/day. An increase in albumin excretion predicts haemodynamic and morphologic changes of diabetic nephropathy. When increased, it is an early indicator of renal failure; the risk of microalbuminuria in diabetics increases when HbA1 value rises > 10%. Microalbuminuria is not invariably associated with renal failure and, in some patients, may regress.

microalbuminuria

Nephrology The excretion of 30-300 mg albumin/day; ↑ albumin excretion predicts hemodynamic and morphologic changes of diabetic nephropathy; when ↑, is an early indicator of renal failure the risk of microalbuminuria in DM ↑ when HbA1 value rises > 10%. See Diabetic nephropathy.

mi·cro·al·bu·mi·nu·ria

(mī'krō-al-bū'min-yūr'ē-ă)
A slight increase in urinary albumin excretion that can be detected using immunoassays but not by means of conventional urineprotein measurements; an early marker for renal disease in patients with diabetes.

microalbuminuria

The presence of almost undetectable traces of the protein albumin in the urine.

mi·cro·al·bu·mi·nu·ria

(mī'krō-al-bū'min-yūr'ē-ă)
A slight increase in urinary albumin excretion that can be detected using immunoassays but not by means of conventional urine protein measurements; an early marker for renal disease in patients with diabetes.
[micro- + albuminuria]
References in periodicals archive ?
The underlying mechanisms between microalbuminuria and the risk for cardiovascular disease are not completely understood; one explanation is that it may be due to more vascular leakiness of albumin in both renal and systemic vessels.
Conclusion: Microalbuminuria was found with increased frequency in type 2 diabetic patients.
In the formula, the estimated prevalence of microalbuminuria is 32% in Nigeria [14] and d is the margin of error at 5% using a 95% confidence interval and adjusting for 10% refusal rate; we calculated a sample size of 330 patients.
The VDBP clearance ratio displays significant independent association with microalbuminuria. The association remained significant even in the presence of confounding variables like age, WC, and HbA1c.
Dunger, "Longitudinal relation between limited joint mobility, height, insulin-like growth factor 1 levels, and risk of developing microalbuminuria: the Oxford regional prospective study," Archives of Disease in Childhood, vol.
The incidence of DR was linked to the presence of microalbuminuria and the duration of disease.
Conclusion: The results of our study concluded that level of serum uric acid and microalbuminuria are significantly correlated to nephropathy in patients having Type-2 diabetes mellitus.
Several studies have demonstrated cost-effectiveness of microalbuminuria screening in high-risk populations leading optimization of patients' care as well as future implementation of CKD screening programs [8, 9, 13].
The association of each biomarker (GDF-15, sST2, and hsTnI) with each renal outcome (incident CKD, incident microalbuminuria, rapid decline in renal function) was modeled using multivariable logistic regression.
Microalbuminuria (MA) is one of the earliest indications of kidney injury in patients with diabetes mellitus and hypertension and is associated with high incidence of cardiovascular morbidity.
Aspartate aminotransferase (AST), alanine aminotransferase (ALT), calcium (Ca), phosphorous (P), alkaline phosphatase (ALP) lactic acid, alpha fetoprotein, triglyceride, cholesterol, uric acid, blood glucose, 24-hour urine microalbuminuria and proteinuria, blood pH and blood gas values at the time of diagnosis and in the follow-up were recorded and these values were compared with the normal values for age and gender and screened in terms of increased liver enzymes, hypertriglyceridemia, hypercholesterolemia, increased lactic acid, increased alpha fetoprotein during the follow-up, proteinuria and microalbuminemia which were expected for GSD 1a and 1b (11,12).